APYX 8-K: SEC filing
Apyx Medical Corporation
Filed with the SEC on · accession 0001437749-26-035079
APYX filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +18.1% by the first close after the filing.
Summary of the filing
Apyx Medical Corporation filed an 8-K furnishing its earnings press release for the third quarter ended September 30, 2026, under Item 2.02 (Results of Operations and Financial Condition).
Key details
How APYX stock reacted
Close before
$2.59
Nov 4, 2026
First close after
+18.15%
$3.06
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for APYX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for APYX?
Click hereFrequently asked questions
What did APYX file with the SEC on Nov 5, 2026?
APYX filed a 8-K (SEC filing). Apyx Medical Corporation filed an 8-K furnishing its earnings press release for the third quarter ended September 30, 2026, under Item 2.02 (Results of Operations and Financial Condition).
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did APYX stock react to this filing?
APYX closed at $2.59 before the filing and $3.06 on Nov 5, 2026 (+18.15%).
Other APYX SEC filings
Get alerts when APYX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days